Standout Papers

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial 2021 2026 2022 2024179
  1. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial (2021)
    Steven G. Kelsen, Ioana Agache et al. Journal of Allergy and Clinical Immunology

Immediate Impact

2 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds
2025 Standout
Atopic dermatitis
2025 Standout
3 intermediate papers

Works of Michael Dolton being referenced

Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis
2022
Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion–Transporting Polypeptides
2012

Author Peers

Author Last Decade Papers Cites
Michael Dolton 325 785 230 579 38 1.3k
Lambert F. R. Span 180 683 55 650 44 1.3k
Lynn Purkins 293 878 77 575 21 1.3k
H Laufen 324 361 122 468 76 1.5k
Elaine Radwanski 298 366 189 416 62 1.7k
J J Pocidalo 348 329 51 672 87 1.5k
Guy Aymard 159 356 44 253 35 1.5k
Deepak Talwar 133 740 63 985 33 1.4k
Robert M. Fielding 237 684 95 376 34 1.5k
Juan J.L. Lertora 122 395 90 214 49 1.7k
David Ashkin 127 1144 101 1010 36 1.7k

All Works

Loading papers...

Rankless by CCL
2026